INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

Rafferty Asset Management, LLC's Holding History (CIK: 0001389426)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 2,484 Value ($000) $328 Avg Close — Range —
Q4 2024
Shares 4,230 Value ($000) $353 Avg Close — Range —
Q3 2024
Shares 5,820 Value ($000) $426 Avg Close — Range —
Q2 2024
Shares 5,951 Value ($000) $408 Avg Close — Range —
Q1 2024
Shares 7,517 Value ($000) $520 Avg Close — Range —
Q4 2023
Shares 6,792 Value ($000) $486 Avg Close — Range —
Q3 2023
Shares 6,266 Value ($000) $326 Avg Close — Range —
Q2 2023
Shares 4,856 Value ($000) $307 Avg Close — Range —
Q1 2023
Shares 4,313 Value ($000) $234 Avg Close — Range —
Q4 2022
Shares 4,467 Value ($000) $236 Avg Close — Range —
Q3 2022
Shares 4,721 Value ($000) $220 Avg Close — Range —
Q2 2022
Shares 4,470 Value ($000) $255 Avg Close — Range —
Q1 2022
Shares 7,446 Value ($000) $456 Avg Close — Range —
Q4 2021
Shares 8,866 Value ($000) $464 Avg Close — Range —
Q3 2021
Shares 9,549 Value ($000) $356 Avg Close — Range —
Q4 2020
Shares 11,666 Value ($000) $371 Avg Close — Range —
Q4 2019
Shares 6,476 Value ($000) $222 Avg Close — Range —
Q3 2019
Shares 12,572 Value ($000) $94 Avg Close — Range —